标题
Inflammation, Immune Activation, and Antiretroviral Therapy in HIV
作者
关键词
Antiretroviral therapy, Inflammation, Immune activation, HIV infection
出版物
Current HIV/AIDS Reports
Volume 14, Issue 3, Pages 93-100
出版商
Springer Nature
发表日期
2017-04-22
DOI
10.1007/s11904-017-0356-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A pilot trial of pentoxifylline on endothelial function and inflammation in HIV-infected patients initiating antiretroviral therapy
- (2016) Samir K. Gupta et al. AIDS
- Differential CD4+ cell count increase and CD4+
- (2016) Ellen S. Chan et al. AIDS
- Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection
- (2016) Theodoros Kelesidis et al. AIDS
- HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls
- (2016) Katherine W. Kooij et al. AIDS
- Monocyte exosomes induce adhesion molecules and cytokines via activation of NF-κB in endothelial cells
- (2016) Norina Tang et al. FASEB JOURNAL
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Haidong Wang et al. LANCET
- Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial
- (2016) Sergio Serrano-Villar et al. PLoS Pathogens
- Inflammatory Markers Associated With Subclinical Coronary Artery Disease: The Multicenter AIDS Cohort Study
- (2016) Hossein Bahrami et al. Journal of the American Heart Association
- Equivalent Decline in Inflammation Markers with Tenofovir Disoproxil Fumarate vs. Tenofovir Alafenamide
- (2016) Nicholas T. Funderburg et al. EBioMedicine
- Monocytes from HIV-infected individuals show impaired cholesterol efflux and increased foam cell formation after transendothelial migration
- (2015) Anna Maisa et al. AIDS
- Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery
- (2015) Anthony R. Cillo et al. AIDS
- Risk of cancer among HIV-infected patients from a population-based nested case–control study: implications for cancer prevention
- (2015) Chang-Hua Chen et al. BMC CANCER
- Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s
- (2015) Theodoros Kelesidis et al. CLINICAL INFECTIOUS DISEASES
- Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz
- (2015) Leonardo Calza et al. CURRENT HIV RESEARCH
- Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation
- (2015) David A. Zidar et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Rosuvastatin Reduces Vascular Inflammation and T-cell and Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy
- (2015) Nicholas T. Funderburg et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061
- (2015) Bret J. Rudy et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy
- (2015) Marie R. McCausland et al. PLoS One
- Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized Trial
- (2015) Steven F. L. van Lelyveld et al. PLoS One
- Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor–Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1
- (2014) Jeffrey L. Lennox et al. ANNALS OF INTERNAL MEDICINE
- Macrophage Inflammatory Markers Are Associated With Subclinical Carotid Artery Disease in Women With Human Immunodeficiency Virus or Hepatitis C Virus Infection
- (2014) Iftach Shaked et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study
- (2014) Suhaib Hattab et al. BMC INFECTIOUS DISEASES
- Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial
- (2014) JE Lake et al. HIV MEDICINE
- Sevelamer Does Not Decrease Lipopolysaccharide or Soluble CD14 Levels But Decreases Soluble Tissue Factor, Low-Density Lipoprotein (LDL) Cholesterol, and Oxidized LDL Cholesterol Levels in Individuals With Untreated HIV Infection
- (2014) Netanya G. Sandler et al. JOURNAL OF INFECTIOUS DISEASES
- Lipopolysaccharide, Immune Activation, and Liver Abnormalities in HIV/Hepatitis B Virus (HBV)–Coinfected Individuals Receiving HBV-Active Combination Antiretroviral Therapy
- (2014) Megan Crane et al. JOURNAL OF INFECTIOUS DISEASES
- Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week results of a randomised, open-label, phase 3b, non-inferiority trial
- (2014) Jose R Arribas et al. LANCET INFECTIOUS DISEASES
- Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir in virologically suppressed adults with HIV (STRATEGY-NNRTI): 48 week results of a randomised, open-label, phase 3b non-inferiority trial
- (2014) Anton Pozniak et al. LANCET INFECTIOUS DISEASES
- Differential penetration of raltegravir throughout gastrointestinal tissue
- (2013) Kristine B. Patterson et al. AIDS
- Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants
- (2013) Frank J. Palella et al. AIDS
- The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial
- (2013) P. W. Hunt et al. BLOOD
- Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results
- (2013) Princy Kumar et al. BMC INFECTIOUS DISEASES
- A Randomized Controlled Pilot Trial of Valacyclovir for Attenuating Inflammation and Immune Activation in HIV/Herpes Simplex Virus 2–Coinfected Adults on Suppressive Antiretroviral Therapy
- (2013) Tae Joon Yi et al. CLINICAL INFECTIOUS DISEASES
- Decreases in Inflammatory and Coagulation Biomarkers Levels in HIV-Infected Patients Switching from Enfuvirtide to Raltegravir: ANRS 138 Substudy
- (2013) Erika F. Silva et al. JOURNAL OF INFECTIOUS DISEASES
- Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada
- (2013) Hasina Samji et al. PLoS One
- Overcoming pharmacologic sanctuaries
- (2013) Theodore J. Cory et al. Current Opinion in HIV and AIDS
- Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients
- (2013) Nicholas T. Funderburg Current Opinion in HIV and AIDS
- HIV Infection and the Risk of Acute Myocardial Infarction
- (2013) Matthew S. Freiberg et al. JAMA Internal Medicine
- Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir
- (2012) Grace A. McComsey et al. AIDS
- Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir
- (2012) Esteban Martínez et al. AIDS
- Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or treated individuals
- (2012) Stefania Piconi et al. AIDS
- Short Communication: Initiation of an Abacavir-Containing Regimen in HIV-Infected Adults Is Associated with a Smaller Decrease in Inflammation and Endothelial Activation Markers Compared to Non-Abacavir-Containing Regimens
- (2012) Corrilynn O. Hileman et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Arterial Inflammation in Patients With HIV
- (2012) Sharath Subramanian et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Biomarkers of Microbial Translocation and Macrophage Activation: Association With Progression of Subclinical Atherosclerosis in HIV-1 Infection
- (2012) Theodoros Kelesidis et al. JOURNAL OF INFECTIOUS DISEASES
- Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks
- (2012) Paul E Sax et al. LANCET
- Smoking and HIV: Prevalence, Health Risks, and Cessation Strategies
- (2012) Alan R. Lifson et al. Current HIV/AIDS Reports
- Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy
- (2011) Duncan Chege et al. AIDS
- All-cause mortality in treated HIV-infected adults with CD4 >=500/mm3 compared with the general population: evidence from a large European observational cohort collaboration
- (2011) et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Immunologic Failure Despite Suppressive Antiretroviral Therapy Is Related to Activation and Turnover of Memory CD4 Cells
- (2011) Michael M. Lederman et al. JOURNAL OF INFECTIOUS DISEASES
- Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
- (2011) Netanya G. Sandler et al. JOURNAL OF INFECTIOUS DISEASES
- Salsalate is poorly tolerated and fails to improve endothelial function in virologically suppressed HIV-infected adults
- (2010) Corrilynn O Hileman et al. AIDS
- Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study
- (2010) Esteban Martinez et al. AIDS
- Disruption of Intestinal CD4+ T Cell Homeostasis Is a Key Marker of Systemic CD4+ T Cell Activation in HIV-Infected Individuals
- (2010) S. N. Gordon et al. JOURNAL OF IMMUNOLOGY
- Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection
- (2010) Jacqueline Neuhaus et al. JOURNAL OF INFECTIOUS DISEASES
- HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study
- (2010) R. K. Heaton et al. NEUROLOGY
- Cytomegalovirus-Specific T Cells Persist at Very High Levels during Long-Term Antiretroviral Treatment of HIV Disease
- (2010) David M. Naeger et al. PLoS One
- Effects of Maraviroc and Efavirenz on Markers of Immune Activation and Inflammation and Associations with CD4+ Cell Rises in HIV-Infected Patients
- (2010) Nicholas Funderburg et al. PLoS One
- The effect of initiating combined antiretroviral therapy on endothelial cell activation and coagulation markers in South African HIV-infected individuals
- (2010) Eric C. M. van Gorp et al. THROMBOSIS AND HAEMOSTASIS
- Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections
- (2010) Jacob D. Estes et al. PLoS Pathogens
- Exposure to HIV-1 Directly Impairs Mucosal Epithelial Barrier Integrity Allowing Microbial Translocation
- (2010) Aisha Nazli et al. PLoS Pathogens
- Relationship between Inflammatory Markers, Endothelial Activation Markers, and Carotid Intima‐Media Thickness in HIV‐Infected Patients Receiving Antiretroviral Therapy
- (2009) Allison C. Ross et al. CLINICAL INFECTIOUS DISEASES
- Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort study
- (2009) N Obel et al. HIV MEDICINE
- Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral Regimen
- (2009) Todd T Brown et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Association of C-Reactive Protein and HIV Infection With Acute Myocardial Infarction
- (2009) Virginia A Triant et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral‐Treated HIV Infection
- (2009) Wei Jiang et al. JOURNAL OF INFECTIOUS DISEASES
- HIV-1 RNA Dysregulates the Natural TLR Response to Subclinical Endotoxemia in Kenyan Female Sex-Workers
- (2009) Richard T. Lester et al. PLoS One
- HIV and Antiretroviral Therapy: Lipid Abnormalities and Associated Cardiovascular Risk in HIV-Infected Patients
- (2008) Donald P Kotler JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Persistence of HIV in Gut‐Associated Lymphoid Tissue despite Long‐Term Antiretroviral Therapy
- (2008) Tae‐Wook Chun et al. JOURNAL OF INFECTIOUS DISEASES
- Maraviroc for Previously Treated Patients with R5 HIV-1 Infection
- (2008) Roy M. Gulick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
- (2008) Lewis H Kuller et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started